Trials / Completed
CompletedNCT05008354
Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam
Investigation of Pyridoxine Effect on Behavioral Adverse Events of Levetiracetam in Adult Patients With Epilepsy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Nasim Tabrizi · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a two-arm parallel group randomized double-blind placebo-controlled trial with the aim of Investigating pyridoxine effect on behavioral side effects of levetiracetam in adult patients with epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pyridoxine | Pyridoxine tablet 40mg once daily |
| DRUG | Placebo | Placebo tablet once daily |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-09-01
- Completion
- 2021-09-01
- First posted
- 2021-08-17
- Last updated
- 2022-03-29
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT05008354. Inclusion in this directory is not an endorsement.